This ETF had been down since early this year and it hasn't improved ever since.
At this rate, it just might return to the $13.50 zone where it all began.
The MACD that I programmed that allow me to see 3 different timeframes all shows down DOWN DOWN!!!!
Guess I shouldn't complaint about it. If you don't know what a downtrend is, you are looking at it and it is...
As I expected prior to Tilray announcing their Quarterly earnings, I expected disappointment and therefore a push down. Contrary to many people being bullish based on the trend appearing of Wyckoff in nature, I focus on the balance sheets and earnings more predominantly than simply basing my decisions on trends.
In today's market manipulation, it is foolish to...
Did Canopy create a double top, or is the stock going to create a Macro higher low & stick in a bottom tmrw or sometime right away next week?? If Canopy doesn't take control of the market tmrw with some big news to offset the market sentiment than don't look down, in my humble opinion which is only worth a grain of sea salt from...….
Time will tell per usual.
HEXO had taken a huge beating for the last 2 months. It was projected to hit $12 this year, turned out the government messed up so badly that the stock plummeted.
HEXO found support at $6.60 range. Today heard more news about pricing issue that black market cannabis is still much cheaper than retail... (as it should)
I can expect this stock to breakthrough...
VGW has been oversold recently due to the Cannabis industry and the overall downfall of the sector. However, often times dollar stocks in the Cannabis industry (and in any sector as a matter of fact), typically are delayed in terms of their rebounds relative to the big players.
The rebound has started for the large players already in the sector and I expect VGW...
While many people have been super bullish on Tilray, I posted a little while ago my reasons why I am not bullish yet on the stock. I predicted their earnings would disappoint and they did.
Tilray had a fake break-out to trick investors, and the stock increased to 46.00 and change today, only to give it all back post-earnings and back in its consolidation to...
EnWave will likely be one of the key hidden gems in the biotechnological industry and will continue to gain volume as time progresses.
Their company focuses on a multitude of revenue streams for dehydration techniques (patented) and has several revenue streams including royalty bearing and selling their equipment to other companies.
This is one of the most...
Downtrend over last few weeks may be over as todays bullish engulfing shows signs of reversal. Watch for break of 0.35 to confirm bull break from falling wedge. Close above 0.35 would also be a hammer on the weekly chart. Good buy right now with strong support at 0.30, price target at recent tops of 0.51, potentially higher with any good news releases.
There is a critical support range from $20-25
Risk-Reward-Ratio above > 5:1 .
Shares now trade nearly 50% below our fair value estimate, as the lack of profitability continues to weigh
on the market price. However, we think focusing on profitability this early in the company’s and industry’s
evolution is misguided.
Triangle play here. All levels are marked, chart is easy to understand. Looks like it bouncing good, fell to .93c and back to 1.09$ right away, so buying pressure is here.
Will see how it plays out on upcoming week.
Expecting considerable upside with this ETF.
Three key targets listed as potentially only the beginning. Obviously fundamentals are important too, but I fully expect the world to progress sufficiently and allow this sector to grow effectively.
Broke a long, deep 6 month downtrend last week. With the announcement of their product stocking shelves on 8/06/19, I can see this cutting through .15 (key resistance) and head up to the.175 level short term. Volume is building, however today's spinning top ( which I believe it is) on the daily may sell us down slightly before legging up IMO. Plan... trading...
Looking at Tilray with the MACD and Megalodon indicators, we can see a buy signal on the daily for Tilray. Something that we've seen only twice before, both times being the start of significant rise. The Daily MACD doesn't have as much room to turn as did previous signals, however it does look a lot sturdier and supportive. As of right now though, we cannot...
Currently testing the big daily trend line, offering great opportunity to buy with a good stop. With more countries in Europe considering legalising cannabis, industry stocks expected to gain a boost soon. Good Luck!
ACB is now trading at an area of critical support. I am playing this area long however if it closes a 3day candle below the 200ema it would be in danger of entering a bear market cycle. The last several months have just been a long period consolidation and that trend is likely to continue.
(Not financial advice)*